| Tumor stage (Union internationale contre le cancer – UICC) |
Five-year-survival |
| Stage I (T1, T2, N0, M0) |
97.10% |
| Stage IIA (T3, N0, M0) |
87.50% |
| Stage IIB (T4, N0, M0) |
71.50% |
| Stage IIIA (T1 / T2, N1, M0) |
87.70% |
| Stage IIIB (T1 / T2, N2, M0) |
75% |
| Stage IIIB (T3, N1, M0) |
68.70% |
| Stage IIIC (T3, N2, M0) |
47.30% |
| Stage IIIC (T4, N1, M0) |
50.50% |
| Stage IIIC (T4, N2, M0) |
27.10% |
| Stage IV (T1-4, N1-2, M) |
5 – 9% |
|
